<DOC>
	<DOCNO>NCT01716845</DOCNO>
	<brief_summary>This study prospectively enroll approximately 660 child , least 18 month le 5 year age , refer pediatric developmental evaluation center . Enrolled child blood drawn RNA gene expression analysis undergo clinical evaluation determine presence absence diagnosis ASD . The sequential co-primary objective study : - To develop algorithm classify blood RNA gene expression pattern maximize agreement classification clinical assessment presence absence Autism Spectrum Disorders ( ASD ) . - To prospectively assess clinical sensitivity specificity blood RNA gene expression classification algorithm ( SDX-002 test ) child refer developmental evaluation clinic possible developmental disorder .</brief_summary>
	<brief_title>SynapDx Autism Gene Expression Analysis Study</brief_title>
	<detailed_description />
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<criteria>1 . Referred developmental evaluation center evaluation possible developmental disorder , isolated motor problem . 2 . Age &gt; = 18 month &lt; 5 year . 3 . Parent/legal guardian inform study sign informed consent form . 1 . Prior reliable diagnosis Autism Spectrum Disorder ( i.e . prior evaluation multidisciplinary team already reliably establish Autism Spectrum Disorder diagnosis ) . 2 . Unable unwilling complete study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>autism</keyword>
	<keyword>autism spectrum disorder</keyword>
	<keyword>RNA</keyword>
	<keyword>gene expression</keyword>
	<keyword>developmental delay</keyword>
</DOC>